High levels of MDR1 mRNA predominate among patients with secondary acute leukemia (secondary AML and secondary ALL), whereas tumor cells of patients with primary acute leukemia (primary AML and primary ALL) and chronic leukemia (CLL) are characterized by moderate and low levels of MDR1 mRNA (Figure 1). Here, ABCB1 is linked to neoplasm.